Idarubicin/cytosine arabinoside and mitoxantrone/etoposide with rhGM-CSF priming for de novo acute myelogenous leukemia - Haas, Rainer; Hunstein, Werner (Acute leukemias ; 4: Prognostic factors and treatment strategies, 1994)